CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Journal Title
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

CANCER BIOTHER RADIO

ISSN / eISSN
1084-9785 / 1557-8852
Aims and Scope
Cancer Biotherapy and Radiopharmaceuticals is the established peer-reviewed journal, with over 25 years of cutting-edge content on innovative therapeutic investigations to ultimately improve cancer management. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.

The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments.
Subject Area

MEDICINE, RESEARCH & EXPERIMENTAL

ONCOLOGY

PHARMACOLOGY & PHARMACY

CiteScore
6.90 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Radiology, Nuclear Medicine and Imaging Q1 #50/312
Medicine - Oncology Q2 #100/366
Medicine - Pharmacology Q2 #89/301
Medicine - Cancer Research Q2 #89/214
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
MEDICINE, RESEARCH & EXPERIMENTAL - SCIE Q3
ONCOLOGY - SCIE Q3
PHARMACOLOGY & PHARMACY - SCIE Q2
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING - SCIE Q2
H-index
55
Country/Area of Publication
UNITED STATES
Publisher
Mary Ann Liebert Inc.
Publication Frequency
Bimonthly
Year Publication Started
1996
Annual Article Volume
46
Open Access
NO
Contact
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started